For the year ending 2025-12-31, PCRX made $726,411K in revenue. $7,034K in net income. Net profit margin of 0.97%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 726,411 | 700,966 | ||
| Cost of goods sold | 149,749 | 170,428 | ||
| Research and development | 117,312 | 81,577 | ||
| Selling, general and administrative | 368,759 | 294,099 | ||
| Amortization of acquired intangible assets | 57,288 | 57,288 | ||
| Goodwill impairment | 0 | 163,243 | ||
| Contingent consideration gains, acquisition-related expenses, restructuring and other | 14,112 | 7,702 | ||
| Total operating expenses | 707,220 | 774,337 | ||
| Income (loss) from operations | 19,191 | -73,371 | ||
| Interest income | 22,732 | 19,689 | ||
| Interest expense | 17,446 | 16,569 | ||
| (loss) gain on early extinguishment of debt | -983 | 7,518 | ||
| Other, net | -6,620 | -373 | ||
| Total other (expense) income, net | -2,317 | 10,265 | ||
| Income (loss) before income taxes | 16,874 | -63,106 | ||
| Income tax expense | 9,840 | 36,454 | ||
| Net income (loss) | 7,034 | -99,560 | ||
| Basic EPS | 0.16 | -2.15 | ||
| Diluted EPS | 0.16 | -2.15 | ||
| Basic Average Shares | 44,566,000 | 46,245,000 | ||
| Diluted Average Shares | 45,042,000 | 46,245,000 | ||
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)